{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:15:47Z","timestamp":1770297347131,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00277-014-2037-9","type":"journal-article","created":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T08:10:57Z","timestamp":1393488657000},"page":"1139-1148","source":"Crossref","is-referenced-by-count":17,"title":["Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy"],"prefix":"10.1007","volume":"93","author":[{"given":"Sylvia T.","family":"Singer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Fineman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginny","family":"Gildengorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Sweeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kurio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Higa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott P.","family":"Vichinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"issue":"14","key":"2037_CR1","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1182\/blood-2010-11-319152","volume":"118","author":"CR Morris","year":"2011","unstructured":"Morris CR, Kim HY, Trachtenberg F, Wood J, Quinn CT, Sweeters N, Kwiatkowski JL, Thompson AA, Giardina PJ, Boudreaux J, Olivieri NF, Porter JB, Neufeld EJ, Vichinsky EP (2011) Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. Blood 118(14):3794\u20133802. doi: 10.1182\/blood-2010-11-319152","journal-title":"Blood"},{"issue":"10","key":"2037_CR2","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","volume":"115","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD (2010) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 115(10):1886\u20131892. doi: 10.1182\/blood-2009-09-243154","journal-title":"Blood"},{"issue":"1","key":"2037_CR3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1378\/chest.107.1.50","volume":"107","author":"A Aessopos","year":"1995","unstructured":"Aessopos A, Stamatelos G, Skoumas V, Vassilopoulos G, Mantzourani M, Loukopoulos D (1995) Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia. Chest 107(1):50\u201353 [see comments]","journal-title":"Chest"},{"issue":"6","key":"2037_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejim.2011.05.013","volume":"22","author":"M Karimi","year":"2011","unstructured":"Karimi M, Musallam KM, Cappellini MD, Daar S, El-Beshlawy A, Belhoul K, Saned MS, Temraz S, Koussa S, Taher AT (2011) Risk factors for pulmonary hypertension in patients with beta thalassemia intermedia. Eur J Intern Med 22(6):607\u2013610. doi: 10.1016\/j.ejim.2011.05.013","journal-title":"Eur J Intern Med"},{"issue":"2","key":"2037_CR5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2141.2000.02376.x","volume":"111","author":"MD Cappellini","year":"2000","unstructured":"Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP (2000) Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 111(2):467\u2013473","journal-title":"Br J Haematol"},{"issue":"11","key":"2037_CR6","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V97.11.3411","volume":"97","author":"A Aessopos","year":"2001","unstructured":"Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A, Joussef J, Rombos J, Loukopoulos D (2001) Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 97(11):3411\u20133416","journal-title":"Blood"},{"issue":"3","key":"2037_CR7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1365-2141.2002.03711.x","volume":"118","author":"V Atichartakarn","year":"2002","unstructured":"Atichartakarn V, Angchaisuksiri P, Aryurachai K, Onpun S, Chuncharunee S, Thakkinstian A, Atamasirikul K (2002) Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E\/beta-thalassaemic patients. Br J Haematol 118(3):893\u2013898","journal-title":"Br J Haematol"},{"issue":"10","key":"2037_CR8","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1538-7836.2010.03940.x","volume":"8","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned M, Cesaretti C, Cappellini MD (2010) Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost 8(10):2152\u20132158. doi: 10.1111\/j.1538-7836.2010.03940.x","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2037_CR9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1160\/TH06-05-0267","volume":"96","author":"A Taher","year":"2006","unstructured":"Taher A, Isma'eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, Cappellini MD (2006) Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost 96(4):488\u2013491","journal-title":"Thromb Haemost"},{"issue":"11","key":"2037_CR10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ajh.20945","volume":"82","author":"P Angchaisuksiri","year":"2007","unstructured":"Angchaisuksiri P, Atichartakarn V, Aryurachai K, Archararit N, Chuncharunee S, Tiraganjana A, Rattanasiri S (2007) Hemostatic and thrombotic markers in patients with hemoglobin E\/beta-thalassemia disease. Am J Hematol 82(11):1001\u20131004. doi: 10.1002\/ajh.20945","journal-title":"Am J Hematol"},{"issue":"11","key":"2037_CR11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3324\/haematol.2009.010546","volume":"94","author":"A Tripodi","year":"2009","unstructured":"Tripodi A, Cappellini MD, Chantarangkul V, Padovan L, Fasulo MR, Marcon A, Mannucci PM (2009) Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma. Haematologica 94(11):1520\u20131527. doi: 10.3324\/haematol.2009.010546","journal-title":"Haematologica"},{"issue":"5","key":"2037_CR12","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1378\/chest.127.5.1523","volume":"127","author":"A Aessopos","year":"2005","unstructured":"Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I, Karagiorga M (2005) Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest 127(5):1523\u20131530","journal-title":"Chest"},{"issue":"3","key":"2037_CR13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-8703(97)70091-7","volume":"134","author":"ZD Du","year":"1997","unstructured":"Du ZD, Roguin N, Milgram E, Saab K, Koren A (1997) Pulmonary hypertension in patients with thalassemia major. Am Heart J 134(3):532\u2013537","journal-title":"Am Heart J"},{"issue":"8","key":"2037_CR14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/08880010802244035","volume":"25","author":"A El-Beshlawy","year":"2008","unstructured":"El-Beshlawy A, Youssry I, El-Saidi S, El Accaoui R, Mansi Y, Makhlouf A, Taher A (2008) Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy. Pediatr Hematol Oncol 25(8):734\u2013743. doi: 10.1080\/08880010802244035","journal-title":"Pediatr Hematol Oncol"},{"issue":"8","key":"2037_CR15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/08880018.2010.503338","volume":"27","author":"G Kiter","year":"2010","unstructured":"Kiter G, Balci YI, Ates A, Hacioglu S, Sari I (2010) Frequency of pulmonary hypertension in asymptomatic beta-thalassemia major patients and the role of physiological parameters in evaluation. Pediatr Hematol Oncol 27(8):597\u2013607. doi: 10.3109\/08880018.2010.503338","journal-title":"Pediatr Hematol Oncol"},{"issue":"11","key":"2037_CR16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.110.988089","volume":"123","author":"D Farmakis","year":"2011","unstructured":"Farmakis D, Aessopos A (2011) Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked. Circulation 123(11):1227\u20131232. doi: 10.1161\/circulationaha.110.988089","journal-title":"Circulation"},{"key":"2037_CR17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1196\/annals.1345.058","volume":"1054","author":"CR Morris","year":"2005","unstructured":"Morris CR, Kuypers FA, Kato GJ, Lavrisha L, Larkin S, Singer T, Vichinsky EP (2005) Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci 1054:481\u2013485. doi: 10.1196\/annals.1345.058","journal-title":"Ann N Y Acad Sci"},{"key":"2037_CR18","author":"G Derchi","year":"2013","unstructured":"Derchi G, Galanello R, Bina P, Cappellini MD, Piga A, Lai ME, Quarta A, Casu G, Perrotta S, Pinto V, Musallam KM, Forni GL, on behalf of the Webthal Pulmonary Arterial Hypertension G (2013) Prevalence and risk factors for pulmonary arterial hypertension in a large group of beta-Thalassemia patients using right heart catheterization: a Webthal(R) study. Circulation. doi: 10.1161\/CIRCULATIONAHA.113.002124","journal-title":"Circulation"},{"issue":"8","key":"2037_CR19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/hrt.2010.212084","volume":"97","author":"S Janda","year":"2011","unstructured":"Janda S, Shahidi N, Gin K, Swiston J (2011) Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart 97(8):612\u2013622. doi: 10.1136\/hrt.2010.212084","journal-title":"Heart"},{"issue":"14","key":"2037_CR20","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1182\/blood-2011-08-370338","volume":"118","author":"DG Nathan","year":"2011","unstructured":"Nathan DG (2011) Guilt by association. Blood 118(14):3758\u20133759. doi: 10.1182\/blood-2011-08-370338","journal-title":"Blood"},{"issue":"3","key":"2037_CR21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1160\/TH06-08-0436","volume":"97","author":"FA Kuypers","year":"2007","unstructured":"Kuypers FA, Larkin SK, Emeis JJ, Allison AC (2007) Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb Haemost 97(3):478\u2013486","journal-title":"Thromb Haemost"},{"issue":"8","key":"2037_CR22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJMoa1010174","volume":"364","author":"A Lal","year":"2011","unstructured":"Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP (2011) Heterogeneity of hemoglobin H disease in childhood. N Engl J Med 364(8):710\u2013718. doi: 10.1056\/NEJMoa1010174","journal-title":"N Engl J Med"},{"issue":"7","key":"2037_CR23","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood-2003-09-3094","volume":"103","author":"V Atichartakarn","year":"2004","unstructured":"Atichartakarn V, Chuncharunee S, Chandanamattha P, Likittanasombat K, Aryurachai K (2004) Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E\/beta-thalassemia patient. Blood 103(7):2844\u20132846","journal-title":"Blood"},{"key":"2037_CR24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/asheducation-2011.1.419","volume":"2011","author":"KL Hassell","year":"2011","unstructured":"Hassell KL (2011) Pulmonary hypertension, tricuspid regurgitant velocity screening, and the nitric oxide pathway. Hematol Am Soc Hematol Educ Program 2011:419\u2013426. doi: 10.1182\/asheducation-2011.1.419","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"2037_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000205186","volume":"83","author":"A Goldfarb","year":"1990","unstructured":"Goldfarb A, Grisaru D, Gimmon Z, Okon E, Lebensart P, Rachmilewitz EA (1990) High incidence of cholelithiasis in older patients with homozygous beta-thalassemia. Acta Haematol 83(3):120\u2013122","journal-title":"Acta Haematol"},{"issue":"6","key":"2037_CR26","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3324\/haematol.12460","volume":"93","author":"A Habib","year":"2008","unstructured":"Habib A, Kunzelmann C, Shamseddeen W, Zobairi F, Freyssinet JM, Taher A (2008) Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia. Haematologica 93(6):941\u2013942. doi: 10.3324\/haematol.12460","journal-title":"Haematologica"},{"issue":"3","key":"2037_CR27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02983790","volume":"77","author":"V Atichartakarn","year":"2003","unstructured":"Atichartakarn V, Angchaisuksiri P, Aryurachai K, Chuncharunee S, Thakkinstian A (2003) In vivo platelet activation and hyperaggregation in hemoglobin E\/beta-thalassemia: a consequence of splenectomy. Int J Hematol 77(3):299\u2013303","journal-title":"Int J Hematol"},{"issue":"8","key":"2037_CR28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V77.8.1749.1749","volume":"77","author":"A Eldor","year":"1991","unstructured":"Eldor A, Lellouche F, Goldfarb A, Rachmilewitz EA, Maclouf J (1991) In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 77(8):1749\u20131753","journal-title":"Blood"},{"issue":"1","key":"2037_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.2830440114","volume":"44","author":"V Borenstain-Ben Yashar","year":"1993","unstructured":"Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A (1993) Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 44(1):63\u201365","journal-title":"Am J Hematol"},{"issue":"1","key":"2037_CR30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2141.1997.1502965.x","volume":"98","author":"A Ruf","year":"1997","unstructured":"Ruf A, Pick M, Deutsch V, Patscheke H, Goldfarb A, Rachmilewitz EA, Guillin MC, Eldor A (1997) In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol 98(1):51\u201356","journal-title":"Br J Haematol"},{"issue":"5","key":"2037_CR31","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1160\/TH08-03-0157","volume":"100","author":"N Goldschmidt","year":"2008","unstructured":"Goldschmidt N, Spectre G, Brill A, Zelig O, Goldfarb A, Rachmilewitz E, Varon D (2008) Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells. Thromb Haemost 100(5):864\u2013870","journal-title":"Thromb Haemost"},{"issue":"5","key":"2037_CR32","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1160\/TH04-04-0234","volume":"92","author":"J Amer","year":"2004","unstructured":"Amer J, Fibach E (2004) Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost 92(5):1052\u20131059. doi: 10.1267\/thro04051052","journal-title":"Thromb Haemost"},{"issue":"6","key":"2037_CR33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/01.ATV.0000071347.69358.D9","volume":"23","author":"PJ Newman","year":"2003","unstructured":"Newman PJ, Newman DK (2003) Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 23(6):953\u2013964. doi: 10.1161\/01.atv.0000071347.69358.d9","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2037_CR34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood.V91.2.500","volume":"91","author":"D Varon","year":"1998","unstructured":"Varon D, Jackson DE, Shenkman B, Dardik R, Tamarin I, Savion N, Newman PJ (1998) Platelet\/endothelial cell adhesion molecule-1 serves as a costimulatory agonist receptor that modulates integrin-dependent adhesion and aggregation of human platelets. Blood 91(2):500\u2013507","journal-title":"Blood"},{"issue":"Spec No","key":"2037_CR35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jprot.2012.06.004","volume":"76","author":"P Chaichompoo","year":"2012","unstructured":"Chaichompoo P, Kumya P, Khowawisetsut L, Chiangjong W, Chaiyarit S, Pongsakul N, Sirithanaratanakul N, Fucharoen S, Thongboonkerd V, Pattanapanyasat K (2012) Characterizations and proteome analysis of platelet-free plasma-derived microparticles in beta-thalassemia\/hemoglobin E patients. J Proteome 76(Spec No):239\u2013250. doi: 10.1016\/j.jprot.2012.06.004","journal-title":"J Proteome"},{"issue":"3","key":"2037_CR36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1160\/TH06-06-0313","volume":"97","author":"EI Sinauridze","year":"2007","unstructured":"Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI (2007) Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 97(3):425\u2013434","journal-title":"Thromb Haemost"},{"issue":"5","key":"2037_CR37","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2010-04-282095","volume":"116","author":"MT Gladwin","year":"2010","unstructured":"Gladwin MT, Barst RJ, Castro OL, Gordeuk VR, Hillery CA, Kato GJ, Kim-Shapiro DB, Machado R, Morris CR, Steinberg MH, Vichinsky EP (2010) Pulmonary hypertension and NO in sickle cell. Blood 116(5):852\u2013854. doi: 10.1182\/blood-2010-04-282095","journal-title":"Blood"},{"issue":"5","key":"2037_CR38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2010-02-268193","volume":"116","author":"HF Bunn","year":"2010","unstructured":"Bunn HF, Nathan DG, Dover GJ, Hebbel RP, Platt OS, Rosse WF, Ware RE (2010) Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 116(5):687\u2013692. doi: 10.1182\/blood-2010-02-268193","journal-title":"Blood"},{"issue":"13","key":"2037_CR39","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","volume":"293","author":"RP Rother","year":"2005","unstructured":"Rother RP, Bell L, Hillmen P, Gladwin MT (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA: J Am Med Assoc 293(13):1653\u20131662. doi: 10.1001\/jama.293.13.1653","journal-title":"JAMA: J Am Med Assoc"},{"issue":"11","key":"2037_CR40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/mnfr.200500076","volume":"49","author":"J Balla","year":"2005","unstructured":"Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Eaton JW, Balla G (2005) Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res 49(11):1030\u20131043. doi: 10.1002\/mnfr.200500076","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"2037_CR41","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V100.3.879","volume":"100","author":"V Jeney","year":"2002","unstructured":"Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G (2002) Pro-oxidant and cytotoxic effects of circulating heme. Blood 100(3):879\u2013887","journal-title":"Blood"},{"issue":"1","key":"2037_CR42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cardiores.2007.06.004","volume":"76","author":"F Bohm","year":"2007","unstructured":"Bohm F, Pernow J (2007) The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76(1):8\u201318. doi: 10.1016\/j.cardiores.2007.06.004","journal-title":"Cardiovasc Res"},{"issue":"1\u20133","key":"2037_CR43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.regpep.2008.08.002","volume":"151","author":"CD Vizza","year":"2008","unstructured":"Vizza CD, Letizia C, Petramala L, Badagliacca R, Poscia R, Zepponi E, Crescenzi E, Nona A, Benedetti G, Ferrante F, Sciomer S, Fedele F (2008) Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension. Regul Pept 151(1\u20133):48\u201353. doi: 10.1016\/j.regpep.2008.08.002","journal-title":"Regul Pept"},{"issue":"7","key":"2037_CR44","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2012-04-422568","volume":"120","author":"A Anthi","year":"2012","unstructured":"Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE (2012) Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. Blood 120(7):1531\u20131532. doi: 10.1182\/blood-2012-04-422568","journal-title":"Blood"},{"issue":"12","key":"2037_CR45","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1002\/ajh.22182","volume":"86","author":"SE Crary","year":"2011","unstructured":"Crary SE, Ramaciotti C, Buchanan GR (2011) Prevalence of pulmonary hypertension in hereditary spherocytosis. Am J Hematol 86(12):E73\u2013E76. doi: 10.1002\/ajh.22182","journal-title":"Am J Hematol"},{"issue":"7\u20138","key":"2037_CR46","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.clinbiochem.2009.12.021","volume":"43","author":"S Riondino","year":"2010","unstructured":"Riondino S, Martini F, La Farina F, Spila A, Guadagni F, Ferroni P (2010) Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions. Clin Biochem 43(7\u20138):666\u2013670. doi: 10.1016\/j.clinbiochem.2009.12.021","journal-title":"Clin Biochem"},{"issue":"8","key":"2037_CR47","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.0000139859.68513.FC","volume":"110","author":"JK Damas","year":"2004","unstructured":"Damas JK, Otterdal K, Yndestad A, Aass H, Solum NO, Froland SS, Simonsen S, Aukrust P, Andreassen AK (2004) Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells. Circulation 110(8):999\u20131005. doi: 10.1161\/01.cir.0000139859.68513.fc","journal-title":"Circulation"},{"issue":"3","key":"2037_CR48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.2003.020040","volume":"64","author":"Y Allanore","year":"2005","unstructured":"Allanore Y, Borderie D, Meune C, Lemarechal H, Weber S, Ekindjian OG, Kahan A (2005) Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers. Ann Rheum Dis 64(3):481\u2013483. doi: 10.1136\/ard.2003.020040","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2037_CR49","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/j.1538-7836.2010.04030.x","volume":"8","author":"PM Mannucci","year":"2010","unstructured":"Mannucci PM (2010) Red cells playing as activated platelets in thalassemia intermedia. J Thromb Haemost 8(10):2149\u20132151. doi: 10.1111\/j.1538-7836.2010.04030.x","journal-title":"J Thromb Haemost"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2037-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2037-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2037-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T20:45:20Z","timestamp":1597524320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2037-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2037-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}